Mergers & Acquisitions

SELECTED REPRESENTATIONS

• Abiomed (U.S.) in its $18 billion acquisition by Johnson & Johnson (U.S.), the largest all-cash medtech deal in history
   
• ACE Limited (Switzerland) in its $29.5 billion acquisition of The Chubb Corporation (U.S.)
   
• Advance (U.S.) in connection with Discovery Communications’ (U.S.) $14.6 billion acquisition of Scripps Interactive (U.S.)
   
• Alcatel-Lucent (France) in its $16.6 billion acquisition by Nokia (Finland)
   
• Alibaba Group (China) in its $2 billion investment in Lazada Group (Singapore)
   
• Amazon.com (U.S.) in its $13.7 billion acquisition of Whole Foods Market (U.S.)
   
• Amgen (U.S.) in its $28.3 billion pending acquisition of Horizon Therapeutics (Ireland), approximately $1.9 billion acquisition of Five Prime Therapeutics (U.S.), $13.4 billion acquisition of worldwide rights to Otezla® from Celgene Corporation (U.S.) in connection with Celgene’s merger with Bristol-Myers Squibb (U.S.) and $10.5 billion acquisition of Onyx Pharmaceuticals (U.S.)
   
• Andeavor (U.S.) in its $35.6 billion acquisition by Marathon Petroleum (U.S.) and $6.4 billion acquisition of Western Refining (U.S.)
   
• Anheuser-Busch InBev (Belgium) in its strategic relationship with a consortium of investors led by Apollo Global Management (U.S.), which acquired a $3 billion minority stake in AB InBev’s U.S.-based metal container plants, $123 billion merger with SABMiller (U.K.) and $20.1 billion acquisition of the remaining stake it didn’t already own in Grupo Modelo (Mexico)
   
• AT&T (U.S.) in its spin-off of WarnerMedia (U.S.) into Discovery (U.S.), under which WarnerMedia combined with Discovery, creating a premier, standalone global entertainment company (named “Most Outstanding Deal of the Year” by The Deal), agreement with TPG Capital (U.S.) that established a new company named DIRECTV that owns and operates AT&T’s U.S. video business unit with an enterprise value of $16.25 billion, $108.7 billion acquisition of Time Warner Inc. (U.S.) and $67 billion acquisition of DIRECTV (U.S.)
   
• Banco Bilbao Vizcaya Argentaria (Spain) in its $11.5 billion sale of BBVA USA Bancshares, including its U.S. banking subsidiary, BBVA USA, to The PNC Financial Services Group (U.S.)
   
• Baxter International (U.S.) in its acquisition of Hillrom (U.S.) for a total enterprise value of $12.4 billion
   
• Bayer (Germany) in its $6.9 billion sale of its Animal Health business to Elanco Animal Health (U.S.), $66 billion acquisition of Monsanto (U.S.), $9 billion sale of selected crop science assets to BASF (Germany) and $14.2 billion acquisition of Merck’s (U.S.) consumer care business
   
• BBA Aviation (U.K.) in its $2.1 billion acquisition of Landmark Aviation (U.S.)
   
• Biohaven Pharmaceuticals (U.S.) in its $11.6 billion acquisition by Pfizer (U.S.)
   
• BNP Paribas (France) in its $16.3 billion sale of Bank of the West (U.S.) to BMO Financial Group (Canada)
   
• Canadian Pacific Railway in its $31 billion acquisition of Kansas City Southern (U.S.), which would create the first rail network connecting the U.S., Mexico and Canada
   
• Citizens Financial Group (U.S.) in its $3.5 billion merger with Investors Bancorp (U.S.) 
   
• Columbia Pipeline Group (U.S.) in its $13 billion acquisition by TransCanada
   
• Concho Resources (U.S.) in its $13.7 billion acquisition by ConocoPhillips (U.S.) and $9.5 billion acquisition of RSP Permian (U.S.)
   
• Cornerstone Building Brands (U.S.) in its $5.8 billion acquisition by Clayton, Dubilier & Rice (U.S.)
   
• Credit Suisse (Switzerland) in its $3.2 billion pending merger with UBS (Switzerland)
   
• CVS (U.S.) in its $12.8 billion acquisition of Omnicare (U.S.)
   
• Delta Air Lines (U.S.) in its strategic partnership with LATAM Airlines Group (Chile) and Delta’s $1.9 billion investment for a 20% stake in LATAM
   
• Deutsche Wohnen (Germany) in its €19 billion business combination with Vonovia (Germany), the largest-ever real estate merger in Germany 
   
• Diageo (U.K.), in multiple transactions including its:
  • $610 million acquisition of Aviation American Gin (U.S.) through the acquisition of Aviation Gin (U.S.) and Davos Brands (U.S.). Aviation American Gin co-owner Ryan Reynolds retains an ongoing ownership interest in the brand.
  • $1 billion acquisition of Casamigos (U.S.) from founders George Clooney, Rande Gerber and Mike Meldman
  • $550 million sale of nineteen brands to Sazerac (U.S.)
     
• Diebold (U.S.) in its $1.8 billion merger with Wincor Nixdorf (Germany)
   
• DISH Network Corporation (U.S.) as lead counsel in DISH’s agreement with T-Mobile (U.S.), Sprint (U.S.) and the U.S. Department of Justice under which DISH acquired Sprint’s prepaid wireless business and entered the U.S. wireless market as the fourth nationwide facilities-based provider
   
• DraftKings (U.S.) in its business combination with Diamond Eagle Acquisition Corp. (U.S.) and SBTech (Isle of Man) and listing on NASDAQ
   
• Drillisch (Germany) in its $10 billion business combination with United Internet (Germany)
   
• Enbridge (Canada) in its $43 billion acquisition of Spectra Energy (U.S.)
   
• First Horizon (U.S.) in its $13.4 billion pending acquisition by TD Bank Group (Canada)
   
• Fiserv (U.S.) in its $22 billion acquisition of First Data Corporation (U.S.)
  
  
• Forest City Realty Trust (U.S.) in its $11.4 billion acquisition by Brookfield Asset Management (Canada)
   
• GGP (U.S.) in its $28 billion acquisition by Brookfield Property Partners (Bermuda)
   
• Haleon Group (U.K.) in its demerger from the GSK Group (U.K.), making Haleon the world’s biggest stand-alone consumer health company
   
• Harris Corporation (U.S.) in its $35 billion merger of equals with L3 Technologies (U.S.) to form L3Harris Technologies (U.S.)
   
• Impax Laboratories (U.S.) in its $5.5 billion merger with Amneal Pharmaceuticals (U.S.)
   
• Intel (U.S.) in connection with Apple’s (U.S.) $1 billion acquisition of the majority of Intel’s smartphone modem business
   
• Kite Pharma (U.S.) in its $11.9 billion acquisition by Gilead Sciences (U.S.)
   
• Kraft Foods Group (U.S.) in its $55 billion merger with H.J. Heinz Company (U.S.) to form The Kraft Heinz Company
   
• M&T Bank (U.S.) in its $8.3 billion acquisition of People’s United Financial (U.S.)
   
• Major League Baseball (U.S.) and MLB Advanced Media (U.S.) (MLBAM) in connection with the sale of a majority ownership interest in MLBAM’s subsidiary, BAMTech (U.S.), to The Walt Disney Company (U.S.) for $1.58 billion
   
• Merck KGaA (Germany) in its $6.4 billion acquisition of Versum Materials (U.S.)
   
• Mitsubishi UFJ Financial Group (Japan) in its $8 billion sale of MUFG Union Bank (U.S.) to U.S. Bancorp
   
• Navistar International (U.S.) in its $3.7 billion acquisition by TRATON (Germany)
   
• Novartis (Switzerland) in its $9.7 billion acquisition of The Medicines Company (U.S.)
   
• OpenAI (U.S.), the developer of ChatGPT and Dall-E, in its multi-billion dollar partnership with Microsoft (U.S.), including in the development of supercomputing systems to accelerate OpenAI’s groundbreaking independent AI research, and enabling the deployment of OpenAI’s models in Microsoft’s consumer and enterprise products
   
• Panera Bread (U.S.) in its $7.5 billion acquisition by JAB (Luxembourg)
   
• Pepco Holdings (U.S.) in its $6.6 billion acquisition by Exelon (U.S.)
   
• Porsche Automobil Holding (Germany) in its €10.1 billion acquisition of 25% of the ordinary voting shares of Porsche AG (Germany) from Volkswagen AG (Germany)
   
• Praxair (U.S.) in its $80 billion merger of equals with Linde (Germany)
   
• Rio Tinto (U.K.) in its $3.1 billion acquisition of Turquoise Hill Resources (Canada)
   
• RR Donnelley & Sons (U.S.) in the spin-off of its financial print and PRS businesses to create three independent, publicly traded companies
   
• Seagen (U.S.) in its $43 billion pending acquisition by Pfizer (U.S.)
   
• Sotheby’s (U.S.) in its $3.7 billion acquisition by BidFair USA, an entity wholly owned by media and telecom entrepreneur as well as art collector, Patrick Drahi
   
• Standard Industries Holdings (U.S.) in its $7 billion acquisition of W. R. Grace & Co. (U.S.)
   
• Standard Investments (U.S.) and Standard Industries (U.S.), as the largest stockholder in GCP Applied Technologies (U.S.), in connection with Saint-Gobain’s (France) $2.3 billion acquisition of all outstanding shares of GCP
   
• State Grid (China) in its $13 billion acquisition of a 94.8% stake in CPFL Energia (Brazil)
   
• Stellantis (Netherlands) (formerly Fiat Chrysler Automobiles) in its $60 billion 50/50 merger with Peugeot (France)
   
• Stellantis (Netherlands) (formerly Fiat Chrysler Automobiles) and Magneti Marelli (Italy) in the $6.5 billion sale of the Magneti Marelli automotive components business to KKR (U.S.) portfolio company CK Holdings Co. (Hong Kong), a holding company of Calsonic Kansei Corporation (Japan)
   
• Stemcentrx (U.S.) in its $9.8 billion acquisition by AbbVie (U.S.)
   
• Sumitovant Biopharma (U.S.) and Sumitomo Pharma (Japan) in their $2.9 billion acquisition of Myovant Sciences (Switzerland)
   
• Suncor Energy (Canada) in its $4.6 billion acquisition of Canadian Oil Sands
   
• SunTrust Banks (U.S.) in its $66 billion merger of equals with BB&T Corporation (U.S.)
   
• Synageva (U.S.) in its $8.4 billion acquisition by Alexion Pharmaceuticals (U.S.)
   
• Syneos Health (U.S.) in its $7.4 billion merger of equals with inVentiv Health (U.S.)
   
• Syntel (U.S.) in its $3.57 billion acquisition by Atos (France)
   
• Teva Pharmaceutical (Israel) in its $40.5 billion acquisition of Allergan Generics (Ireland)
   
• Tiffany & Co. (U.S.) in its approximately $16 billion acquisition by LVMH Moët Hennessy Louis Vuitton (France)
   
• Unisys (U.S.) in its $1.2 billion sale of its U.S. Federal business to Science Applications International Corporation (SAIC) (U.S.)
   
• UnitedHealth Group (U.S.) in connection with Optum’s (U.S.) $6 billion acquisition of LHC Group (U.S.), $13.8 billion acquisition of Change Healthcare (U.S.) and $4.3 billion acquisition of DaVita Medical Group (U.S.), its $2.8 billion acquisition of Empresas Banmédica (Chile) and the $12.8 billion combination of its free-standing pharmacy care services business OptumRx with Catamaran Corporation (U.S.)
   
• Verifone Systems (U.S.) in its $3.4 billion acquisition by an investor group led by Francisco Partners (U.S.)
   
• Vornado (U.S.) in the spin-off and $8.4 billion merger of its Washington, D.C. business with The JBG Companies (U.S.) to form JBG Smith Properties